Urine Concentrating Ability in Infants With Sickle Cell Disease: Baseline Data From the Phase III Trial of Hydroxyurea (BABY HUG)

Pediatric Blood and Cancer - United States
doi 10.1002/pbc.22189
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG): Challenges of Study Design

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2009English

The Effect of Hydroxyurea in Sickle Cell Disease Patients

IOSR Journal of Dental and Medical Sciences
2017English

Effect of Hydroxyurea on Priapism in Men With Sickle Cell Disease

West Indian Medical Journal
Medicine
2016English

Fetal Hemoglobin Levels in African American and Hispanic Children With Sickle Cell Disease at Baseline and in Response to Hydroxyurea

Journal of Pediatric Hematology/Oncology
Child HealthOncologyPediatricsHematologyPerinatology
2011English

Effects of Alpha-Thalassemia and Sickle Polymerization Tendency on the Urine-Concentrating Defect of Individuals With Sickle Cell Trait.

Journal of Clinical Investigation
Medicine
1991English

Neutrophils Remain Detrimentally Active in Hydroxyurea-Treated Patients With Sickle Cell Disease

PLoS ONE
Multidisciplinary
2019English

Adhesion Molecules and Hydroxyurea in the Pathophysiology of Sickle Cell Disease

Haematologica
Hematology
2008English

Hydroxyurea in Sickle Cell Disease: Our Experience in Western India

Indian Journal of Hematology and Blood Transfusion
Hematology
2015English

The Osmotic Concentrating Ability in Healthy Infants and Children

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1965English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy